BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35165016)

  • 1. Can we treat with radiation breast cancer patients with covid-19 infection? Results from a prospective study.
    Allali S; Servois V; Beddok A; Fourquet A; Kirova Y
    Cancer Radiother; 2022 Jun; 26(4):577-584. PubMed ID: 35165016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the early adverse effects of radiotherapy in breast cancer patients with COVID-19: Prospective single institutional study.
    Allali S; Servois V; Beddok A; Fourquet A; Kirova Y
    Breast J; 2021 Nov; 27(11):824-827. PubMed ID: 34435418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Concurrent radiation therapy and dual HER2 blockade in breast cancer: Assessment of toxicity].
    Ben Dhia S; Loap P; Loirat D; Vincent-Salomon A; Cao K; Escalup L; Fourquet A; Kirova Y
    Cancer Radiother; 2021 Jul; 25(5):424-431. PubMed ID: 33771453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
    Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
    Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study.
    Dautruche A; Belin L; Cottu P; Bontemps P; Lemanski C; de la Lande B; Baumann P; Missohou F; Lévy C; Peignaux K; Reynaud-Bougnoux A; Denis F; Gobillion A; Pernin V; Kirova Y
    Cancer Radiother; 2018 May; 22(3):222-228. PubMed ID: 29650388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of acute skin toxicity of breast radiotherapy using thermography: Results of a prospective single-centre trial.
    Maillot O; Leduc N; Atallah V; Escarmant P; Petit A; Belhomme S; Sargos P; Vinh-Hung V
    Cancer Radiother; 2018 May; 22(3):205-210. PubMed ID: 29678596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and late toxicities of patients infected with SARS-CoV-2 and treated for cancer with radiation therapy during the COVID-19 pandemic.
    Beddok A; Chevrier M; Calugaru V; Minsat M; Dendale R; Lantz O; Servois V; Paoletti X; Crehange G
    Int J Radiat Biol; 2021; 97(10):1436-1440. PubMed ID: 34269644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy after sentinel lymph node biopsy for early stage breast cancer using a magnetic tracer: Results of a single institutional prospective study of tolerance.
    Bazire L; Alran S; El Bamrani S; Gaujal L; Vincent-Salomon A; Tardivon A; Kirova YM
    Cancer Radiother; 2019 Feb; 23(1):23-27. PubMed ID: 30553652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thoracic computerised tomography scans in one hundred eighteen orthopaedic patients during the COVID-19 pandemic: identification of chest lesions; added values; help in managing patients; burden on the computerised tomography scan department.
    Hernigou J; Cornil F; Poignard A; El Bouchaibi S; Mani J; Naouri JF; Younes P; Hernigou P
    Int Orthop; 2020 Aug; 44(8):1571-1580. PubMed ID: 32506142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
    Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity.
    Ajgal Z; de Percin S; Diéras V; Pierga JY; Campana F; Fourquet A; Kirova YM
    Cancer Radiother; 2017 Apr; 21(2):114-118. PubMed ID: 28347625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Results of a Highly Performing Conformal Electron Therapy Technique for Chest Wall Irradiation After Mastectomy.
    Grellier Adedjouma N; Chevrier M; Fourquet A; Costa E; Xu H; Berger F; Campana F; Laki F; Beuzeboc P; Lefeuvre D; Fournier-Bidoz N; Kirova YM
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):206-214. PubMed ID: 28586961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area.
    Vuagnat P; Frelaut M; Ramtohul T; Basse C; Diakite S; Noret A; Bellesoeur A; Servois V; Hequet D; Laas E; Kirova Y; Cabel L; Pierga JY; ; Bozec L; Paoletti X; Cottu P; Bidard FC
    Breast Cancer Res; 2020 May; 22(1):55. PubMed ID: 32460829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors of acute radiodermatitis in breast cancer after adjuvant radiotherapy treated with RT3D or IMRT].
    Thomas A; Keller A; Menoux I; Brahimi Y; Vigneron C; Le Fèvre C; Chambrelant I; Pietta GA; Guihard S; Clavier JB; Antoni D; Noël G
    Cancer Radiother; 2022 Sep; 26(5):684-691. PubMed ID: 35227594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer: Single-center Preliminary Results.
    Zolcsák Z; Loirat D; Fourquet A; Kirova YM
    Am J Clin Oncol; 2020 Dec; 43(12):895-901. PubMed ID: 33027084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute toxicity of breast cancer irradiation with modulated intensity by tomotherapy
    Aoulad N; Massabeau C; de Lafontan B; Vieillevigne L; Hangard G; Ciprian C; Chaltiel L; Moyal É; Izar F
    Cancer Radiother; 2017 May; 21(3):180-189. PubMed ID: 28499662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer.
    Cuaron JJ; Chon B; Tsai H; Goenka A; DeBlois D; Ho A; Powell S; Hug E; Cahlon O
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):284-91. PubMed ID: 25754632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.